Funding · Company
Odyssey Therapeutics, Inc.
Boston, MABiotech & Pharma
Odyssey Therapeutics, Inc. of Boston, MA has disclosed $591M across 4 Form D offerings filed with the SEC between Oct 14, 2021 and Dec 4, 2025.
$591M
Total disclosed
4
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$117M
Form D · Aug 14, 2024 ↗
Q3 2024
· 1 amendment, first filed Dec 15, 2023
· target $121M
$168M
Form D · Oct 27, 2022 ↗
Q4 2022
· target $175M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001882782Offerings on file4
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →